Medifast (NYSE:MED) CEO Acquires $178,724.58 in Stock

Medifast Inc (NYSE:MED) CEO Daniel Chard bought 17,678 shares of the stock in a transaction on Friday, March 20th. The stock was acquired at an average cost of $10.11 per share, for a total transaction of $178,724.58. Following the acquisition, the chief executive officer directly owned 17,678 shares in the company, valued at approximately $178,724.58. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Medifast Stock Up 2.4%

Shares of NYSE MED opened at $9.98 on Tuesday. Medifast Inc has a 12 month low of $9.22 and a 12 month high of $15.46. The company has a market cap of $109.69 million, a P/E ratio of -5.84 and a beta of 0.52. The business’s 50 day moving average is $10.68 and its two-hundred day moving average is $11.63.

Medifast (NYSE:MED) last posted its quarterly earnings data on Tuesday, February 17th. The specialty retailer reported ($0.55) earnings per share for the quarter, beating the consensus estimate of ($0.76) by $0.21. Medifast had a negative return on equity of 4.27% and a negative net margin of 4.84%.The company had revenue of $75.10 million during the quarter, compared to analysts’ expectations of $71.40 million. Medifast has set its FY 2026 guidance at -2.750–1.55 EPS and its Q1 2026 guidance at -0.700–0.15 EPS. Sell-side analysts expect that Medifast Inc will post 0.51 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MED. Charles Schwab Investment Management Inc. grew its stake in shares of Medifast by 30.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 776,829 shares of the specialty retailer’s stock valued at $8,297,000 after purchasing an additional 181,618 shares during the period. Bank of America Corp DE raised its holdings in shares of Medifast by 14.2% in the 3rd quarter. Bank of America Corp DE now owns 452,543 shares of the specialty retailer’s stock worth $6,186,000 after buying an additional 56,174 shares in the last quarter. Lido Advisors LLC bought a new position in shares of Medifast during the 3rd quarter worth approximately $4,521,000. Dimensional Fund Advisors LP boosted its stake in Medifast by 9.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 326,240 shares of the specialty retailer’s stock valued at $3,484,000 after buying an additional 27,871 shares in the last quarter. Finally, Steamboat Capital Partners LLC acquired a new stake in Medifast in the 4th quarter valued at $2,952,000. Institutional investors own 95.51% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on MED. Weiss Ratings restated a “sell (d)” rating on shares of Medifast in a research report on Thursday, January 22nd. Wall Street Zen raised shares of Medifast from a “sell” rating to a “hold” rating in a research report on Saturday, March 21st. Finally, Stephens reduced their target price on shares of Medifast from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Thursday, February 19th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $12.00.

Medifast Company Profile

Medifast, Inc (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight‐loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight‐management solutions.